Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Role of N-linked glycans in the interactions of recombinant HCV envelope glycoproteins with cellular receptors.

Chen PC, Chuang PK, Chen CH, Chan YT, Chen JR, Lin SW, Ma C, Hsu TL, Wong CH.

ACS Chem Biol. 2014 Jul 18;9(7):1437-43. doi: 10.1021/cb500121c. Epub 2014 May 15.

PMID:
24766301
2.

Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.

Helle F, Vieyres G, Elkrief L, Popescu CI, Wychowski C, Descamps V, Castelain S, Roingeard P, Duverlie G, Dubuisson J.

J Virol. 2010 Nov;84(22):11905-15. doi: 10.1128/JVI.01548-10. Epub 2010 Sep 15.

3.

Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization.

Falkowska E, Kajumo F, Garcia E, Reinus J, Dragic T.

J Virol. 2007 Aug;81(15):8072-9. Epub 2007 May 16.

4.

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.

Lozach PY, Amara A, Bartosch B, Virelizier JL, Arenzana-Seisdedos F, Cosset FL, Altmeyer R.

J Biol Chem. 2004 Jul 30;279(31):32035-45. Epub 2004 May 27.

5.

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.

Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, Houles C, Fieschi F, Schwartz O, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R.

J Biol Chem. 2003 May 30;278(22):20358-66. Epub 2003 Feb 27.

6.

Hepatitis C virus entry: potential receptors and their biological functions.

Cocquerel L, Voisset C, Dubuisson J.

J Gen Virol. 2006 May;87(Pt 5):1075-84. Review.

PMID:
16603507
7.

Ficolin-2 inhibits hepatitis C virus infection, whereas apolipoprotein E3 mediates viral immune escape.

Zhao Y, Ren Y, Zhang X, Zhao P, Tao W, Zhong J, Li Q, Zhang XL.

J Immunol. 2014 Jul 15;193(2):783-96. doi: 10.4049/jimmunol.1302563. Epub 2014 Jun 13.

8.

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.

Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, Dragic T, Olson WC.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4498-503. Epub 2003 Apr 3.

9.

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans.

Helle F, Wychowski C, Vu-Dac N, Gustafson KR, Voisset C, Dubuisson J.

J Biol Chem. 2006 Sep 1;281(35):25177-83. Epub 2006 Jun 29.

10.

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.

Cormier EG, Durso RJ, Tsamis F, Boussemart L, Manix C, Olson WC, Gardner JP, Dragic T.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14067-72. Epub 2004 Sep 15.

11.

Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.

Morizono K, Ku A, Xie Y, Harui A, Kung SK, Roth MD, Lee B, Chen IS.

J Virol. 2010 Jul;84(14):6923-34. doi: 10.1128/JVI.00435-10. Epub 2010 May 19.

12.

Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.

Holla A, Skerra A.

Protein Eng Des Sel. 2011 Sep;24(9):659-69. doi: 10.1093/protein/gzr016. Epub 2011 May 2.

PMID:
21540232
13.

Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.

Tong Y, Zhu Y, Xia X, Liu Y, Feng Y, Hua X, Chen Z, Ding H, Gao L, Wang Y, Feitelson MA, Zhao P, Qi ZT.

J Virol. 2011 Mar;85(6):2793-802. doi: 10.1128/JVI.01818-10. Epub 2010 Dec 22.

14.

Frontal affinity chromatography analysis of constructs of DC-SIGN, DC-SIGNR and LSECtin extend evidence for affinity to agalactosylated N-glycans.

Yabe R, Tateno H, Hirabayashi J.

FEBS J. 2010 Oct;277(19):4010-26. doi: 10.1111/j.1742-4658.2010.07792.x. Epub 2010 Sep 1.

15.

Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.

Douam F, Dao Thi VL, Maurin G, Fresquet J, Mompelat D, Zeisel MB, Baumert TF, Cosset FL, Lavillette D.

Hepatology. 2014 Mar;59(3):776-88. doi: 10.1002/hep.26733. Epub 2014 Jan 28.

PMID:
24038151
16.

Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.

Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, Depraetere S, van Kooyk Y, Geijtenbeek TB.

J Virol. 2004 Aug;78(15):8322-32.

17.

Hepatitis C virus entry: role of host and viral factors.

Samreen B, Khaliq S, Ashfaq UA, Khan M, Afzal N, Shahzad MA, Riaz S, Jahan S.

Infect Genet Evol. 2012 Dec;12(8):1699-709. doi: 10.1016/j.meegid.2012.07.010. Epub 2012 Aug 2. Review.

PMID:
22878095
18.

Solution NMR analyses of the C-type carbohydrate recognition domain of DC-SIGNR protein reveal different binding modes for HIV-derived oligosaccharides and smaller glycan fragments.

Probert F, Whittaker SB, Crispin M, Mitchell DA, Dixon AM.

J Biol Chem. 2013 Aug 2;288(31):22745-57. doi: 10.1074/jbc.M113.458299. Epub 2013 Jun 20.

19.

Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN.

Op den Brouw ML, de Jong MA, Ludwig IS, van der Molen RG, Janssen HL, Geijtenbeek TB, Woltman AM.

J Viral Hepat. 2008 Sep;15(9):675-83. doi: 10.1111/j.1365-2893.2008.00993.x. Epub 2008 May 14.

PMID:
18482282
20.

DC-SIGN: binding receptors for hepatitis C virus.

Wang QC, Feng ZH, Nie QH, Zhou YX.

Chin Med J (Engl). 2004 Sep;117(9):1395-400. Review.

PMID:
15377434

Supplemental Content

Support Center